I’m Taking Out Some ‘Insurance’ on My Portfolio With These 2 Stocks
Here’s why I’m getting into this ‘boring’ insurance play and a biotech name.
Here’s why I’m getting into this ‘boring’ insurance play and a biotech name.
The market is in a transitional phase as we await earnings.